BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

200 related articles for article (PubMed ID: 28070713)

  • 1. Porous mannitol carrier for pulmonary delivery of cyclosporine A nanoparticles.
    Leung SS; Wong J; Guerra HV; Samnick K; Prud'homme RK; Chan HK
    AAPS J; 2017 Mar; 19(2):578-586. PubMed ID: 28070713
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Lecithin/TPGS-based spray-dried self-microemulsifying drug delivery systems: In vitro pulmonary deposition and cytotoxicity.
    Ishak RA; Osman R
    Int J Pharm; 2015 May; 485(1-2):249-60. PubMed ID: 25772421
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Enhanced dissolution of inhalable cyclosporine nano-matrix particles with mannitol as matrix former.
    Yamasaki K; Kwok PC; Fukushige K; Prud'homme RK; Chan HK
    Int J Pharm; 2011 Nov; 420(1):34-42. PubMed ID: 21864662
    [TBL] [Abstract][Full Text] [Related]  

  • 4. New nano-matrix oral formulation of nanoprecipitated cyclosporine A prepared with multi-inlet vortex mixer.
    Suzuki H; Hamao S; Seto Y; Sato H; Wong J; Prud'homme RK; Chan HK; Onoue S
    Int J Pharm; 2017 Jan; 516(1-2):116-119. PubMed ID: 27845213
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Spray-freeze-drying production of thermally sensitive polymeric nanoparticle aggregates for inhaled drug delivery: effect of freeze-drying adjuvants.
    Cheow WS; Ng ML; Kho K; Hadinoto K
    Int J Pharm; 2011 Feb; 404(1-2):289-300. PubMed ID: 21093560
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Aerosol delivery of nanoparticles in uniform mannitol carriers formulated by ultrasonic spray freeze drying.
    D'Addio SM; Chan JG; Kwok PC; Benson BR; Prud'homme RK; Chan HK
    Pharm Res; 2013 Nov; 30(11):2891-901. PubMed ID: 23893019
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Impact of excipient choice on the aerodynamic performance of inhalable spray-freeze-dried powders.
    Wanning S; Süverkrüp R; Lamprecht A
    Int J Pharm; 2020 Aug; 586():119564. PubMed ID: 32590097
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Porous and highly dispersible voriconazole dry powders produced by spray freeze drying for pulmonary delivery with efficient lung deposition.
    Liao Q; Yip L; Chow MYT; Chow SF; Chan HK; Kwok PCL; Lam JKW
    Int J Pharm; 2019 Apr; 560():144-154. PubMed ID: 30731259
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Freeze-dried mannitol for superior pulmonary drug delivery via dry powder inhaler.
    Kaialy W; Nokhodchi A
    Pharm Res; 2013 Feb; 30(2):458-77. PubMed ID: 23070603
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Spray freeze-dried porous microparticles of a poorly water-soluble drug for respiratory delivery.
    Niwa T; Mizutani D; Danjo K
    Chem Pharm Bull (Tokyo); 2012; 60(7):870-6. PubMed ID: 22790820
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Solid dispersions of itraconazole for inhalation with enhanced dissolution, solubility and dispersion properties.
    Duret C; Wauthoz N; Sebti T; Vanderbist F; Amighi K
    Int J Pharm; 2012 May; 428(1-2):103-13. PubMed ID: 22414388
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Poloxamer 407/TPGS Mixed Micelles as Promising Carriers for Cyclosporine Ocular Delivery.
    Grimaudo MA; Pescina S; Padula C; Santi P; Concheiro A; Alvarez-Lorenzo C; Nicoli S
    Mol Pharm; 2018 Feb; 15(2):571-584. PubMed ID: 29313693
    [TBL] [Abstract][Full Text] [Related]  

  • 13. In vitro evaluation of the effect of cyclodextrin complexation on pulmonary deposition of a peptide, cyclosporin A.
    Matilainen L; Järvinen K; Toropainen T; Näsi E; Auriola S; Järvinen T; Jarho P
    Int J Pharm; 2006 Aug; 318(1-2):41-8. PubMed ID: 16624508
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Constant size, variable density aerosol particles by ultrasonic spray freeze drying.
    D'Addio SM; Chan JG; Kwok PC; Prud'homme RK; Chan HK
    Int J Pharm; 2012 May; 427(2):185-91. PubMed ID: 22322208
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Large porous particles for respiratory drug delivery. Glycine-based formulations.
    Ogienko AG; Bogdanova EG; Trofimov NA; Myz SA; Ogienko AA; Kolesov BA; Yunoshev AS; Zubikov NV; Manakov AY; Boldyrev VV; Boldyreva EV
    Eur J Pharm Sci; 2017 Dec; 110():148-156. PubMed ID: 28479348
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Stabilization of IgG1 in spray-dried powders for inhalation.
    Schüle S; Schulz-Fademrecht T; Garidel P; Bechtold-Peters K; Frieb W
    Eur J Pharm Biopharm; 2008 Aug; 69(3):793-807. PubMed ID: 18477504
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Characterization of a cyclosporine solid dispersion for inhalation.
    Zijlstra GS; Rijkeboer M; Jan van Drooge D; Sutter M; Jiskoot W; van de Weert M; Hinrichs WL; Frijlink HW
    AAPS J; 2007 Jun; 9(2):E190-9. PubMed ID: 17614361
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Preparation and in vivo absorption evaluation of spray dried powders containing salmon calcitonin loaded chitosan nanoparticles for pulmonary delivery.
    Sinsuebpol C; Chatchawalsaisin J; Kulvanich P
    Drug Des Devel Ther; 2013; 7():861-73. PubMed ID: 24039397
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Preparation of honokiol-loaded chitosan microparticles via spray-drying method intended for pulmonary delivery.
    Li X; Guo Q; Zheng X; Kong X; Shi S; Chen L; Zhao X; Wei Y; Qian Z
    Drug Deliv; 2009 Apr; 16(3):160-6. PubMed ID: 19514976
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Design, characterization, and aerosol dispersion performance modeling of advanced co-spray dried antibiotics with mannitol as respirable microparticles/nanoparticles for targeted pulmonary delivery as dry powder inhalers.
    Li X; Vogt FG; Hayes D; Mansour HM
    J Pharm Sci; 2014 Sep; 103(9):2937-2949. PubMed ID: 24740732
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.